Literature DB >> 20430377

Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.

Henri Sova1, Laure Morin-Papunen, Ulla Puistola, Peeter Karihtala.   

Abstract

OBJECTIVE: To investigate oxidative stress and angiogenetic factors in polycystic ovary syndrome (PCOS).
DESIGN: Prospective cohort study.
SETTING: University outpatient clinic.
SUBJECTS: Fifty women with PCOS were divided into two groups: body mass index (BMI) >27 kg/m(2) (n = 25) and BMI <27 kg/m(2) (n = 25). The control group consisted of 20 age- and BMI-matched healthy women. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Enzyme-linked immunosorbent assays were used to measure serum levels of 8-hydroxydeoxyguanosine (8-OHdG), angiopoietin-2, and vascular endothelial growth factor (VEGF). RESULT(S): Women with PCOS had significantly lower serum 8-OHdG levels (mean 137.8 pg/mL, range 53.4-282.9 pg/mL) compared with the control subjects (mean 219.78 pg/mL, 124.6-372.4 pg/mL). This difference was obvious in both lean (BMI <27 kg/m(2)) and obese (BMI >27 kg/m(2)) subjects. Concentrations of VEGF were higher among obese subjects with PCOS. CONCLUSION(S): Serum 8-OHdG levels are significantly lower in women with PCOS than in healthy controls. The clinical significance of this finding is discussed.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430377     DOI: 10.1016/j.fertnstert.2010.03.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome.

Authors:  Ana Teresa Brinca; Ana Cristina Ramalhinho; Ângela Sousa; António Hélio Oliani; Luiza Breitenfeld; Luís A Passarinha; Eugenia Gallardo
Journal:  Biomedicines       Date:  2022-05-27

2.  Angiopoietin-1 and angiopoietin-2 are altered in polycystic ovarian syndrome (PCOS) during controlled ovarian stimulation.

Authors:  Reshef Tal; David B Seifer; Richard V Grazi; Henry E Malter
Journal:  Vasc Cell       Date:  2013-10-24

3.  Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study.

Authors:  Po-Kai Yang; Chia-Hong Chou; Chin-Hao Chang; Shee-Uan Chen; Hong-Nerng Ho; Mei-Jou Chen
Journal:  Reprod Biol Endocrinol       Date:  2020-07-13       Impact factor: 5.211

4.  Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes.

Authors:  Johanna Pölönen; Pekka Pinola; Justiina Ronkainen; Alex I Blakemore; Jessica L Buxton; Juha S Tapanainen; Stephen Franks; Terhi T Piltonen; Sylvain Sebert; Laure Morin-Papunen
Journal:  Eur J Endocrinol       Date:  2022-09-29       Impact factor: 6.558

5.  Reduced Angiopoietin-2 as a Predictive Biomarker for Clomiphene Citrate Resistance in Polycystic Ovary Syndrome.

Authors:  Luxmipratha Rajendiran; Hanumanthappa Nandeesha; Thyagaraju Chitra
Journal:  J Hum Reprod Sci       Date:  2021-06-28

Review 6.  Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers.

Authors:  Tao Zuo; Minghui Zhu; Wenming Xu
Journal:  Oxid Med Cell Longev       Date:  2015-12-06       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.